Skip to main content

Table 3 Comparative analysis between children exposed to different protease inhibitors at CAISM/UNICAMP from 2000 to 2015

From: Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study

Variables

ATV

NFV

LPV/R

p*

ATV x LPV/R

NFV x LPV/R

ATV x NFV

n

%

n

%

n

%

RR

CI 95%

RR

CI 95%

RR

CI 95%

Gestational age (weeks)

 <34 weeks

0

0

4

3.1

11

2.7

0.0922

NC

 

0.71

0.47–1.07

NC

 

 >=34 weeks

25

100

126

96.9

402

97.3

  

1.00

   

Gestational age (Capurro)

 <37 weeks

6

24

22

16.9

99

24

0.0922

1.00

0.41–2.44

0.71

0.47–1.07

1.43

0.63–3.26

 >=37 weeks

19

76

108

83.1

314

76

1.00

 

1.00

 

1.00

 

Birth weight

 <2500 g

5

19.2

24

18.2

104

24.6

0.1242

0.74

0.29–1.92

0.74

0.50–1.10

1.06

0.44–2.57

 >=2500 g

21

80.8

108

81.8

318

75.4

1.00

 

1.00

 

1.00

 

Birth weight

 <1500 g

0

0

8

6.1

13

3.1

0.023

NC

 

1.5

0.85–2.65

NC

 

 1500 g - 2499 g

5

19.2

16

12.1

91

21.6

  

0.59

0.36–0.95

1.46

0.62–3.45

 >=2500 g

21

80.8

108

81.8

318

75.4

  

1.5

 

1.00

 

Weight adequacy for GA

 Adequate for GA

19

76

110

83.3

312

75.4

0.0004

1.00

 

1.00

 

1.00

 

 Small for GA

5

20

15

11.4

97

23.4

0.85

0.33–2.23

0.51

0.31–0.85

1.7

0.71–4.03

 Large for GA

1

4

7

5.3

5

1.2

2.90

0.46–18.31

2.24

1.34–3.71

0.85

0.13–5.56

5th minute Apgar

 <7

0

0

1

0.8

2

0.5

0.5603**

  

1.4

0.28–6.97

  

 >=7

25

100

131

99.2

418

99.5

  

1.00

   

Neonatal disease

 Yes

8

30.8

27

21.3

122

29.4

0.0723

1.06

0.47–2.38

0.71

0.49–1.04

1.5

0.71–3.15

 No

18

69.2

100

78.7

293

70.6

1.00

 

1.00

 

1.00

 

Birth defect

 Yes

1

3.8

16

12.1

43

10.1

0.5135

0.37

0.05–2.67

1.16

0.74–1.82

0.33

0.05–2.30

 No

25

96.2

116

87.9

382

89.9

1.00

 

1.00

 

1.00

 

Anemia

 Yes

2

8.3

33

27.5

92

23.1

0.3183

0.32

0.08–1.33

1.2

0.85–1.69

0.28

0.07–1.14

 No

22

91.7

87

72.5

307

76.9

1.00

 

1.00

 

1.00

 

Thrombocytopenia

 Yes

3

12.0

6

5.0

13

3.3

0.0755

3.49

1.16–10.45

1.4

0.71–2.76

2.05

0.75–5.56

 No

22

88.0

113

95.0

387

96.8

1.00

 

1.00

 

1.00

 

Hepatic changes

 Yes

5

25.0

28

90.3

63

24.1

<  0.0001

1.04

0.39–2.77

20.62

6.43–66.07

0.18

0.08–0.42

 No

15

75.0

3

9.7

198

75.9

1.00

 

1.00

 

1.00

 

TOTAL

26

 

132

 

425

        
  1. GA gestacional age, ATV atazanavir, NFV nelfinavir, LPV lopinavir, R ritonavir
  2. (#) Numbers are different due to the lack of information on some patients
  3. (# #) Not calculated
  4. *Chi-square, **Fisher Exact